For the big drug firms, market is ripe for expansion into herbals
Article Abstract:
Several major pharmaceutical companies are venturing into the arena of herbal supplements and botanical products. Although the field has been led by independent supplement manufacturers, several herbal supplement product lines are now being introduced by big-time drug companies. These include the Centrum Herbals line of six botanical products, from Whitehall-Robins Healthcare, a unit of American Home Products Corp.; Warner-Lambert's Quanterra Mental Sharpness and Quanterra Prostate botanical supplements; One-A-Day herbal products from Bayer Corp., which include Cholesterol Health and Cold Season tablets; Venastat and Movana from Pharmaton, a unit of Boehringer Ingelheim Pharmaceuticals; and SmithKline Beecham's four herbal products that were test-marketed under the Abtei brand name.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Starting at the bottom
Article Abstract:
Linters is aiming to take 3% to 5% of the $6-billion tissue-paper market with Purely Cotton, the first and only bathroom tissue made solely of cotton fiber. The company has invested $15 million into Purely Cotton, which is expected to collide with long-time market giants Georgia-Pacific, Fort James, Procter & Gamble and Kimberly-Clark. Founded by Scottish brothers Willy and Tim Patterson-Brown, Linters is hoping its target market share would translate into annual revenue of $180 million to $300 million. The firm plans to launch products for babies, personal hygiene and incontinence.
Comment:
Aims to take 3% to 5% of $6-bil tissue-paper mkt w/ Purely Cotton, the first & only bathroom tissue made solely of cotton fiber
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Honda joins sports-car arena with S2000
Article Abstract:
Honda plans to market starting in summer 1999 the two-seater S2000 convertible in the US. The planned sale of the S2000 in the US marks Honda's foray into the market for sports cars. The small S2000 convertible is equipped with a 240-horsepower, four-cylinder and two-liter engine, as well as rear-wheel-drive and six-speed manual-transmission capabilities. The S2000 is expected to be an excellent rival sports car to the Mercedes-Benz SLK, the Porsche Boxster and the BMW Z3 sports cars due to the S2000's power and price range, which is probably in the low $30,000.
Comment:
Plans to market starting in summer 1999 the two-seater S2000 convertible in the US
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Quick meals for a weeknight. The time is ripe for apples & pears. Back to the roots: for winter warmth, try these easy, one-dish meals
- Abstracts: How to find your first job. We are responsible. How much care can I give?
- Abstracts: Save the children. Before teenagers become criminals. How to save a marriage before it's in trouble
- Abstracts: Lord of the rings. Carr's riding rough
- Abstracts: Grapes of wealth: while there is one stand-out performer, many wines are still good investments. Silver bodgie's gilded perch